✦ LIBER ✦

Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls

✍ Scribed by Court Pedersen; Morten Breindahl; Naresh Aggarwal; Johan Berglund; György Oroszlán; Sven Arne Silfverdal; Péter Szüts; Michael O'Mahony; Marie-Pierre David; Kurt Dobbelaere; Gary Dubin; Dominique Descamps

Book ID: 116595103
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 389 KB
Volume: 50
Category: Article
ISSN: 1054-139X
DOI: 10.1016/j.jadohealth.2011.10.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Immunogenicity of the HPV-16/

Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls

✍ Doris M. Rivera Medina; Alejandra Valencia; Alet de Velasquez; Li-Min Huang; Rom 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Co-administration of human papillomaviru

Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls

✍ Channa E. Schmeink; Ruud L.M. Bekkers; Ann Josefsson; Jan H. Richardus; Katarina 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women

✍ José Garcia-Sicilia; Tino F. Schwarz; Alfonso Carmona; Klaus Peters; Jean-Elie M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Immunogenicity and safety of human papil

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women

✍ Neerja Bhatla; Vanita Suri; Partha Basu; Surendra Shastri; Sanjoy K. Datta; Dan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04 Adjuvanted Vaccine in Healthy Males Aged 10–18 Years

✍ M. Lehtinen; T. Petäjä; H. Keränen; T. Karppa; A. Kawa; S. Lantela; H. Levänen; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

✍ Tiina Petäjä; Heli Keränen; Tiina Karppa; Anna Kawa; Sirkku Lantela; Mari Siitar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 414 KB